SCHEMBL9280795

SCHEMBL9280795

CCCCCOC(=O)c1ccccc1O[C]=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.69
MAPK1 P28482 4/20 0.69
CYP3A4 P08684 3/20 0.69
TP53 P04637 1/20 0.69
ALDH1A1 P00352 8/20 0.68
LMNA P02545 4/20 0.68
L3MBTL1 Q9Y468 3/20 0.62
TDP1 Q9NUW8 3/20 0.62
KDM4E B2RXH2 3/20 0.59
HSD17B10 Q99714 2/20 0.59
POLB P06746 1/20 0.59
MAPT P10636 3/20 0.50
MEN1 O00255 1/20 0.50
NR1I2 O75469 1/20 0.50
CHRM2 P08172 1/20 0.50
ADRA2A P08913 1/20 0.50
OPRK1 P41145 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A3 Q01959 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160215 0.96 TSHR (0.69) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL5157954 0.90 ALDH1A1 (0.67) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL30173476 0.85 TSHR (0.78) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL3805742 0.85 TSHR (0.78) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL9636466 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL5515133 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL12816232 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL7078029 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL2853795 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1
SCHEMBL17961072 0.84 ALDH1A1 (0.79) TSHRMAPK1CYP3A4TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5478808-A Blood disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed